Search alternatives:
marked decrease » marked increase (Expand Search)
small decrease » small increased (Expand Search)
can small » non small (Expand Search), a small (Expand Search), rab small (Expand Search)
marked decrease » marked increase (Expand Search)
small decrease » small increased (Expand Search)
can small » non small (Expand Search), a small (Expand Search), rab small (Expand Search)
-
1
-
2
-
3
-
4
-
5
Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients.
Published 2025“…This decrease was larger in the disconnected than in the contralateral cortex. …”
-
6
-
7
Biases in larger populations.
Published 2025“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
-
8
-
9
-
10
RT-qPCR Primer.
Published 2024“…The findings of the current study revealed a significant decrease in miR-1247-3p expression in CRC cells, especially those resistant to drugs. …”
-
11
miR-1247-3p plasmid.
Published 2024“…The findings of the current study revealed a significant decrease in miR-1247-3p expression in CRC cells, especially those resistant to drugs. …”
-
12
Dual luciferase primer.
Published 2024“…The findings of the current study revealed a significant decrease in miR-1247-3p expression in CRC cells, especially those resistant to drugs. …”
-
13
shCCND1 plasmid.
Published 2024“…The findings of the current study revealed a significant decrease in miR-1247-3p expression in CRC cells, especially those resistant to drugs. …”
-
14
S1 Raw images -
Published 2024“…The findings of the current study revealed a significant decrease in miR-1247-3p expression in CRC cells, especially those resistant to drugs. …”
-
15
Introduction to the dataset.
Published 2024“…The findings of the current study revealed a significant decrease in miR-1247-3p expression in CRC cells, especially those resistant to drugs. …”
-
16
-
17
-
18
-
19
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
20
The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.
Published 2025“…Parameter values: interaction strengths were drawn from a half-normal distribution of zero mean and a standard deviation of 0.2, and strength for consumers was made no larger than the strength for resources. …”